Evidence map›Paper›PMID 37337131›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[Value of autocrine motility factors in the prediction of the disease progression of PBC- associated hepatocellular carcinoma].

M Y Zhang, H Xie, J Zhao, Q S Liang, L Han, X R Zhai, B S Li, Z S Zou, Y Sun

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

M Y ZhangGraduate School of PLA General Hospital, Beijing 100853, China Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
H XieDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
J ZhaoDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
Q S LiangDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
L HanDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
X R ZhaiDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China Peking University 302 Clinical Medical School, Beijing 100039, China.
B S LiDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
Z S ZouDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
Y SunDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
Chinese PLA General Hospital · CN

Funding

National Natural Science Foundation of China 81873564Traditional Chinese Medicine Innovation Team and Talent Support Plan ZYYCXTD-C-202005
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver Cirrhosis, BiliaryLiver NeoplasmsDisease ProgressionGlucose-6-Phosphate IsomeraseHumansLiver Cirrhosis, AlcoholicProspective StudiesUrsodeoxycholic AcidGlucose-6-Phosphate IsomeraseUrsodeoxycholic AcidAutotaxinHepatocellular carcinomaPrimary biliary cholangitis

Identifiers

PMID37337131
PMCPMC12850650
OpenAlexW4381308410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.